MediCann Health

What MediCann Health does

MediCann Health Aust Pty Ltd is a Perth-based, privately held plant-based medicine company founded in 2019 that operates a vertically integrated portfolio spanning clinical services, consumer wellness products, pharmaceutical sponsorship, and clinical research. Its core operational subsidiary, MediCann Clinics, delivers telehealth consultations Australia-wide and in-person appointments across multiple clinics in Perth, Western Australia. The company serves medical patients seeking plant-based medicinal treatments for conditions including concussion, Parkinson's Disease, MND, and Endometriosis, alongside wellness consumers purchasing hemp-based nutraceuticals, foods, and terpene-based products through its wholly-owned brands Hemp Brothers and EndoScent.

The company generates revenue across four streams: clinical consultation services via MediCann Clinics, direct-to-consumer sales of hemp and terpene wellness products, licensing/sponsorship revenue from pharmaceutical brands Maali and BOB, and research partnership arrangements. Underlying technology comprises four proprietary formulas developed for repeated mild traumatic brain injury (concussion) treatment, which completed a 2-year pre-clinical trial in partnership with the Perron Institute. The company holds additional research collaborations with Curtin University aimed at progressing proprietary formulations toward registered medicine status and potential Pharmaceutical Benefits Scheme listing.

Operationally, MediCann Health is a micro-cap private company with approximately 5 employees and limited publicly disclosed financial information. Pricing for clinical consultations is not publicly disclosed, with patients directed to contact clinics directly. Go-to-market combines inside sales (telehealth), enterprise field sales (through healthcare provider networks), and D2C e-commerce for wellness brands. Strategic positioning centers on leveraging clinical research credibility, proprietary formulations, and multi-channel distribution to capture patient share within the Australian medicinal cannabis and wellness markets.

Name

MediCann Health

Legal name

MediCann Health Aust Pty Ltd

Website

https://medicannhealth.com.au

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

1–10 employees

Short description

MediCann Health is a Perth-based, privately held plant-based medicine company founded in 2019 that operates telehealth and in-person clinics Australia-wide, sells hemp and terpene wellness products through wholly-owned brands, and runs clinical research programs targeting concussion, Parkinson's, and MND.

Ownership category

akta.pro rank

Product category

Medical Cannabis Services

NAICS

Offices of Physicians (6211)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Prescription-Based Digital Clinics (Condition-Specific Rx Programs) (HLALAAAD)

Keywords

• Medical cannabis clinics
• Plant-based medicine
• Cannabis telehealth
• Hemp wellness products
• Clinical research services

Headquarters

HQ city

Perth

HQ country

Australia

HQ region

Oceania

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain, Others

Revenue model

1. Clinical Services: Revenue generated through MediCann Clinics providing medical consultations and plant-based medicine prescriptions to patients via telehealth and in-person appointments.
2. Pharmaceutical Sponsorship: Sponsorship revenue from pharmaceutical brands Maali and BOB within the Australian pharmaceutical industry.
3. Consumer Wellness Products: Direct sales of Hemp Brothers (hemp nutraceuticals and foods) and EndoScent (terpene-based wellness products) to consumers.
4. Clinical Research Services: Research partnership arrangements with academic institutions contributing to product development and potential future registered medicines.

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels4 records

Core offering

MediCann Health delivers plant-based medicinal treatments through its wholly-owned subsidiary MediCann Clinics, which provides telehealth consultations Australia-wide and in-person appointments across multiple Perth, WA clinics. It complements these clinical services with two consumer wellness brands — Hemp Brothers (Australian-grown hemp nutraceuticals and foods) and EndoScent (terpene-based wellness products) — and sponsors the Australian pharmaceutical brands Maali and BOB. The company also pursues clinical research, including a completed 2-year pre-clinical trial on proprietary concussion formulations in partnership with Perron Institute and Curtin University.

Product overview

MediCann Health operates as a plant-based medicine company with a portfolio of subsidiary and branded products. The core offering is MediCann Clinics, a telehealth and in-person patient care service, complemented by two consumer wellness brands: Hemp Brothers (hemp-based food and nutraceuticals) and EndoScent (terpene-based wellness products). The company also sponsors pharmaceutical brands Maali and BOB in the Australian market. Research divisions focus on clinical applications for concussion, Parkinson's Disease, MND, and Endometriosis.

Differentiator

Problem solved

Functional benefit

Brands

• MediCann Clinics: A subsidiary providing reliable, professional and patient-centred care through multiple clinics around Perth, WA, and telehealth appointments Australia wide.
• Hemp Brothers
• EndoScent
• Maali
• BOB

Products and services

• MediCann Clinics Wholly-owned subsidiary delivering reliable, professional, patient-centred medical cannabis care through telehealth appointments Australia-wide and in-person consultations across multiple Perth clinics. Targets patients seeking plant-based medicinal treatments for conditions including concussion, Parkinson's Disease, MND, and Endometriosis, as well as general wellness and pet health.
• Hemp Brothers Wholly-owned food and wellness brand offering a range of premium Australian-grown hemp products, including nutraceuticals and foods, sold direct-to-consumer through the Hemp Brothers e-commerce storefront. Targets health-conscious wellness consumers seeking natural, Australian-grown products.
• EndoScent Wholly-owned wellness brand offering a range of terpene-based products designed to assist with everyday ailments and lifestyle concerns, providing natural relief for the whole family. Sold direct-to-consumer via the EndoScent e-commerce storefront.
• Maali (sponsored pharmaceutical brand) Sponsored pharmaceutical brand within the Australian pharmaceutical industry, with MediCann Health acting as the sponsor. Targets the Australian pharmaceutical market as a regulated brand presence.
• BOB (sponsored pharmaceutical brand) Sponsored pharmaceutical brand within the Australian pharmaceutical industry, with MediCann Health acting as the sponsor. Targets the Australian pharmaceutical market as a regulated brand presence.

Quantifiable outcome

• Completed 2-year pre-clinical trial on concussion treatment with 4 different formulas showing extremely encouraging results

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Three partnerships are on record, tiered core.

• Perron InstitutecoreStrategic or Co-development Partner · 1 January 2019World-renowned research institute partnership for concussion research. MediCann Health completed a 2-year pre-clinical trial in partnership with Perron Institute testing 4 different formulas for repeated mild traumatic brain injury treatment, yielding extremely encouraging results.
• Curtin UniversitycoreStrategic or Co-development Partner · 1 January 2019Academic research partnership focused on cannabis and plant-based medicine research. Collaboration supports MediCann Health's goal of conducting clinical trials and achieving registered medicine status for their proprietary formulas.
• MediCann ClinicscoreStrategic or Co-development Partner · 1 January 2019Wholly-owned subsidiary focusing on providing reliable, professional and patient-centred medical cannabis care through multiple clinics around Perth, WA and telehealth appointments Australia-wide.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Polln: Australian cannabis clinic platform focused on streamlined patient access to medicinal cannabis via telehealth. Closely comparable to MediCann Clinics on consultation model and condition-specific prescribing workflows.
• CDA Clinics (Cannabis Doctors Australia): Australian network of medicinal cannabis clinics offering both in-person and telehealth consultations for plant-based medicine prescriptions. Direct comparable to MediCann Clinics in patient journey, prescriber model and condition-specific prescribing focus.
• MOCA Health: Australian telehealth-first medicinal cannabis clinic providing consultations and prescriptions nationwide. Operates with similar clinical delivery model to MediCann Clinics, competing for the same patient segments.
• Alternaleaf: Australian medicinal cannabis telehealth clinic network providing direct-to-consumer consultations and plant-based medicine prescriptions Australia-wide. Closely comparable to MediCann Clinics in delivery model, regulatory positioning and patient target.

Broad incumbents

• Cann Group: ASX-listed Australian medicinal cannabis company with cultivation, manufacturing and product operations. Broad incumbent in the same Australian cannabis therapeutics category, comparable on regulatory positioning but operating at larger scale and different stage of the value chain.
• Zelira Therapeutics: ASX-listed Australian clinical-stage cannabis therapeutics company focused on validated, pharmaceutical-grade cannabinoid medicines. Comparable to MediCann Health on clinical research orientation and indication-specific development strategy.
• Bod Australia: ASX-listed Australian company developing and commercialising plant-based medicinal cannabis and CBD products. Comparable to MediCann Health on product portfolio and consumer wellness branding strategy.
• Althea Group Holdings: ASX-listed Australian medicinal cannabis company spanning cultivation, product portfolio and patient access. Comparable to MediCann Health across the Australian plant-medicine value chain, though at significantly larger scale.
• Little Green Pharma: ASX-listed Australian medicinal cannabis producer and distributor. Comparable to MediCann Health as an established Australian plant-medicine operator, though vertically focused on cultivation and supply rather than clinic delivery.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/medicann-health

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MediCann Health